Evidence map›Paper›PMID 30681958›Full record

ArticleJournal of studies on alcohol and drugs. Supplement2019

The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.

Linda Montanari, Alessandro Pirona, Bruno Guarita, Dagmar Hedrich, Jane Mounteney, Julian Vicente

Abstract read
In one paragraph

Article in Journal of studies on alcohol and drugs. Supplement, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. System Performance Measurement: Implications for Service Planning.Journal of studies on alcohol and drugs. Supplement · 2019
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Linda MontanariEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Alessandro PironaEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Bruno GuaritaEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Dagmar HedrichEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Jane MounteneyEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Julian VicenteEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
European Monitoring Centre for Drugs and Drug Addiction · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on drug users in contact with treatment services. The article discusses the implementation of the TDI in the European countries and describes the main results, limitations, and future perspectives.

methodThe TDI provides a common format for reporting data on clients entering treatment as a result of their drug use and related problems during each calendar year. Its technical protocol defines which clients should be reported at European level and represents the minimum common set of items each national monitoring system should be able to report to the European Monitoring Centre for Drugs and Drug Addiction.

resultsIn 2015, 29 European countries reported data on 467,811 clients entering drug treatment from 6,846 drug treatment units. Most clients were men in their 30s and had problems related to heroin or cannabis use; patterns of drug use differed geographically. Over the past decade, clients' profiles and drug use patterns changed from young heroin injectors seeking treatment to drug clients with diversified drug use patterns and profiles.

conclusionsThe TDI is the largest drug dataset in Europe, and its data is increasingly used in European and national data analysis. The use of a common drug-treatment-monitoring tool across a group of countries provides a useful instrument for policymakers, professionals, and managers working in the drug treatment field.

Indexed as

Ambulatory Care FacilitiesEuropeHealth Services Needs and DemandHumansSubstance Abuse Treatment CentersSubstance-Related DisordersTreatment Outcome

Identifiers

PMID30681958
PMCPMC6377015
OpenAlexW2912756623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.